NeoTrident

What NeoTrident does

NeoTrident (创腾科技), founded in 2005 and headquartered in Beijing with a subsidiary in Suzhou, is a privately held scientific software company that provides R&D digitalization and AI-augmented molecular simulation platforms to life sciences and materials science enterprises. The product portfolio is organized around three integrated platforms: iLabPower, a 16-module R&D innovation platform anchored on an ELN compliant with FDA 21 CFR Part 11 and covering reagent inventory, project management, compound registration, biologics/ADC handling via HELM, instrument management, LIMS-adjacent workflows, and pre-validated Verification Cloud; MaXFlow, an AI+molecular simulation platform supporting small molecule and biologics drug design and materials physics/chemistry, including the proprietary NeoMD molecular dynamics engine and an AI Agent module; and SDH, a Scientific Data Genome Platform that fuses ELN, instrument, and external database (PubChem, ChEMBL, ZINC, PDB) data with an AI assistant for natural language querying. The company also distributes third-party scientific software (Certara's Phoenix WinNonlin, Phoenix NLME, Pinnacle 21, and EXTEDO's eCTDmanager) in China.

NeoTrident serves more than 1,200 customers across two primary verticals: biopharmaceutical/biotech (innovative small molecules, biologics, ADCs, CAR-T cell therapy, mRNA therapeutics, vaccines, generics, and CDMOs) and materials/chemical (OLED, photoresists, new energy, petrochemicals, aerospace, and specialty chemicals). Named adopters include YiLian Bio (900% ROI case study), BeiHeng Bio, PackGene, Guangzhou Baiyunshan, United Lab, Sinopec RIPP, Dingjing Tech, and Shanghai Huayi. Revenue is generated through SaaS subscriptions (primary, with claimed 75% faster/cheaper deployment versus on-premise), perpetual on-premise licenses, and professional services including validation support and the Neoteng Academy training program. Distribution combines direct enterprise field sales split between Beijing (Northern China) and Suzhou (Southern China) offices, a self-service free-trial funnel at ilabpower.com, the annual ICMS&AI academic conference, and international distribution signaled via the neotridentglobal.com English-language site. The company is founder-led (Cao Lingxiao, 曹凌霄), has no disclosed external institutional control beyond two private funding rounds (Huatai Health Fund in 2018 and Chengwei Capital in 2022), and holds ISO 27001 and ISO 9001 certifications.

Name

NeoTrident

Legal name

北京创腾科技有限公司

Website

https://neotrident.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

NeoTrident (创腾科技) is a Beijing-based scientific software company that provides integrated ELN-centric R&D digitalization, AI-driven molecular simulation (MaXFlow), and scientific data fusion (SDH) platforms to 1,200+ life sciences and materials science enterprises across China.

Ownership category

akta.pro rank

Product category

Scientific R&D Lifecycle Management Software

NAICS

Software Publishers (5132), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Electronic lab notebook
• Molecular simulation software
• Pharmaceutical R&D informatics
• AI drug design platform
• Laboratory information management

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Platform Subscriptions (SaaS/Premise): Subscription-based SaaS model for iLabPower, MaXFlow, and SDH platforms. Supports both SaaS cloud deployment and on-premise/private cloud deployment. SaaS offering features 75% faster deployment and 75% lower cost. Verification cloud provides pre-validated SaaS platform to reduce compliance overhead for GxP customers.
2. Perpetual Software Licenses: Traditional perpetual license model available alongside SaaS, particularly for enterprise customers preferring on-premise deployment. Includes platform modules like ELN, CIMS, PM, RegMS, BIMS, IM, and domain-specific tools (Phoenix WinNonlin for PK/PD, Pinnacle 21 for CDISC, Extedo eCTDmanager for electronic submissions).
3. Professional Services (Implementation, Training, Validation): Implementation services, system validation support, training programs (Neoteng Academy), and consulting for digital transformation. Validation cloud provides pre-built DQ/IQ/OQ packages to reduce GxP system validation time by over 50%.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

NeoTrident develops and sells SaaS-based scientific innovation lifecycle management software for life sciences and materials science R&D. Its three core platforms — iLabPower (ELN-centric R&D digitalization with 16 modules), MaXFlow (molecular simulation and AI for drug/materials design), and SDH (scientific data fusion and analytics) — enable pharmaceutical, biotech, and chemical companies to digitize laboratory workflows, run molecular simulations, and leverage AI for drug discovery and materials R&D. The platforms are FDA 21 CFR Part 11-compliant and deployed via SaaS or on-premise licensing to enterprise and mid-market customers.

Product overview

NeoTrident (创腾科技) offers a three-platform integrated portfolio for life sciences and materials science R&D: (1) iLabPower研发创新数字化平台 (R&D Innovation Digitalization Platform) - the core ELN-centric platform comprising 16 modules including ELN, CIMS, PM, RegMS, DOE, Draw, SEQ, BIMS, IM, SIP, SM, MM, IDS, OPEN, and 验证云; (2) SDH科学数据基因组平台 (Scientific Data Genome Platform) - a data hub for multi-source data fusion, governance, and AI-ready dataset preparation; and (3) MaXFlow分子模拟与人工智能平台 (Molecular Simulation & AI Platform) - for molecular modeling, AI-driven drug/materials design, and scientific computation. The platform supports SaaS deployment and integrates with external scientific databases (PubChem, ChEMBL, ZINC, PDB), ERP/LIMS systems, and enterprise communication tools.

Differentiator

Problem solved

Functional benefit

Brands

• iLabPower: R&D innovation digital platform providing ELN, CIMS, PM, RegMS, DOE, Draw, SEQ, BIMS, IM, SIP, SM, MM, IDS, OPEN, and Verification Cloud modules for laboratory and R&D management.
• MaXFlow
• SDH (科学数据基因组平台)
• AI-EKB (AI智研中枢)

Products and services

• iLabPower R&D Innovation Digital Platform (研发创新数字化平台) Core SaaS platform based on cloud deployment with 2-week onboarding, integrating Verification Cloud and Innovation Cloud drivers, covering 16 R&D management modules for life sciences and materials science enterprises.
• iLabPower ELN Electronic Lab Notebook (电子实验记录本) FDA 21 CFR Part 11-compliant electronic lab notebook supporting SaaS deployment for paperless laboratory data recording and management, with built-in HELM editor for ADC and peptide complex molecule design.
• SDH Scientific Data Genome Platform (科学数据基因组平台) Data fusion and analytics platform for life sciences and materials science research scenarios, supporting automatic extraction, cleansing, fusion, and visualization of multi-source heterogeneous data, integrated with PubChem, ChEMBL, ZINC, and PDB external databases.
• MaXFlow Molecular Simulation and AI Platform (分子模拟与人工智能平台) Next-generation molecular simulation and AI fusion platform enabling free models and free data, supporting small molecule and biologic drug design, and materials simulation calculation for pharma, biotech, and chemical industries.
• iLabPower Verification Cloud (验证云) SaaS cloud platform compliant with verification requirements, helping enterprises reduce system verification difficulty and cycle time through pre-validated DQ/IQ/OQ packages that cut GxP system validation time by over 50%.
• iLabPower LES Flexible Production Execution System / flexi-MES (柔性生产执行系统) Flexible production execution system (flexi-MES) designed for multi-product, small-batch, rapidly-changing industrial scenarios, using process-oriented design with graphical SOP configuration. Reduces human error by 75%+ and data review turnaround time by 70%, connects upward to ERP and downward to LIMS for full data integration.
• AI-EKB Enterprise AI Knowledge Base (AI智研中枢) Enterprise-grade AI knowledge base platform using RAG technology to transform experimental records into structured enterprise knowledge, supporting multi-source document parsing, knowledge slicing and indexing, intelligent Q&A with source citation and traceability, and multi-turn dialogue. Integrates deeply with iLabPower ELN with same permission system.
• PK/PD Pharmacokinetics/Pharmacodynamics Platform (药代/药效动力学平台) Pharmacokinetics and pharmacodynamics analysis platform distributed by NeoTrident in China as authorized partner for Certara Phoenix WinNonlin, Phoenix NLME, and Trial Simulator software for PK/PD modeling.
• CDISC Dataset Visualization and Validation Platform (数据集可视化和验证平台) CDISC-compliant dataset visualization and validation platform distributed by NeoTrident in China as authorized partner for Certara Pinnacle 21 Enterprise CDISC software.
• PBPK Physiologically-Based Pharmacokinetics Platform (生理药代动力学平台) Physiologically-based pharmacokinetics modeling platform for pharmaceutical R&D.
• Extedo eCTDmanager Electronic Regulatory Submission System (电子申报管理系统) Electronic regulatory submission system in eCTD format, with NeoTrident as authorized Chinese distributor and implementation partner for EXTEDO's eCTDmanager software, providing sales, implementation, and support services for regulatory submissions in China.

Quantifiable outcome

• SaaS deployment reduces implementation time by 75% and cost by 75%
• +12 more outcomes

Named customers25 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability12 records

Feature10 records

Partnerships

Nine partnerships are on record, tiered core, major and minor.

• China Pharmaceutical University (中国药科大学)coreStrategic or Co-development PartnerStrategic partnership to build a scientific data-driven new drug R&D intelligent platform with China Pharmaceutical University, leveraging SDH scientific data genome and MaXFlow AI platforms for intelligent drug discovery.
• Fudan University School of Pharmacy Molecular Simulation and Design Center (复旦大学药学院分子模拟与设计中心)coreStrategic or Co-development PartnerCollaboration with Fudan University's School of Pharmacy to advance intelligent new drug R&D through molecular simulation, integrating academic research excellence with NeoTrident's technology platforms.
• New Leading Pharma (新领先医药)majorStrategic or Co-development PartnerStrategic partnership to build an AI+CXO intelligent integrated service platform. New Leading Pharma provides CXO services while NeoTrident provides digital infrastructure for intelligent transformation, creating an industry benchmark.
• Carbon Silicon Intelligence (碳硅智慧)majorTechnology or IntegrationStrategic partnership to build a one-stop AI intelligent drug design platform. Carbon Silicon Intelligence's AI drug design capabilities integrated with NeoTrident's platforms for comprehensive drug discovery solutions.
• Certara (including Phoenix WinNonlin, Phoenix NLME, Pinnacle 21)majorTechnology or IntegrationNeoTrident distributes Certara's PK/PD modeling software (Phoenix WinNonlin, Phoenix NLME), Trial Simulator, and Pinnacle 21 Enterprise CDISC software in China, integrating these tools into the iLabPower platform ecosystem.
• EXTEDO (eCTDmanager)majorTechnology or IntegrationAuthorized Chinese distributor and implementation partner for EXTEDO's eCTDmanager electronic regulatory submission system. Provides sales, implementation, and support services for eCTD format submissions in China.
• iLabPower Innovation Cloud Community (iLabPower协同创新云社区)minorChannel Partner/ Reseller/ DistributorOnline community platform connecting multiple research institutes and enterprises using iLabPower. Community members share experiences, access resources, and collaborate on the platform.
• YiLian Bio (宜联生物医药)coreStrategic or Co-development PartnerStrategic collaboration where YiLian Bio uses NeoTrident's full platform suite (ELN, PM, RegMS, SDH) for ADC drug R&D, achieving 900% ROI and winning the 2023 Suzhou AI application scenario demonstration project.
• Dingjing Tech (鼎材科技)coreStrategic or Co-development PartnerDeepened collaboration to implement iLabPower LES and SDH platforms for OLED materials and photoresist R&D and production at Hefei manufacturing base. Originally started with iLabPower R&D digital platform and SDH in 2022, expanded to production operations.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Genedata: Genedata provides biopharma R&D data management and analytics platforms (e.g., Screener, Expressionist) for large molecule and small molecule discovery. Comparable to NeoTrident's SDH scientific data platform and iLabPower modules for enterprise biopharma R&D workflows.
• Chemical Computing Group (CCG): CCG develops the Molecular Operating Environment (MOE) for drug discovery, including pharmacophore modeling, QSAR, and biologics tools. Directly comparable to NeoTrident's MaXFlow for computational chemistry and computer-aided drug design customers.
• OpenEye Scientific (Cadence Design Systems): OpenEye develops molecular modeling and cheminformatics software (e.g., OMEGA, FRED, ROCS) for drug discovery. Directly comparable to NeoTrident's MaXFlow small molecule drug design module for pharmaceutical computational chemistry users.
• Benchling: Benchling is a cloud-native life sciences R&D platform with ELN, LIMS, and molecular biology capabilities targeting biopharma. Directly competes with NeoTrident's iLabPower ELN-centric platform for biotech and pharma R&D digitization customers, especially in China where both are expanding.
• IDBS: IDBS offers a life sciences R&D platform covering ELN, biorepositories, and data management for biopharma. Comparable to NeoTrident's iLabPower for biotech and pharma customers requiring integrated R&D data capture and workflow management.
• Dotmatics: Dotmatics provides an integrated scientific informatics platform (ELN, LIMS, decision support) for drug discovery and materials science. Directly comparable to NeoTrident's three-platform approach spanning iLabPower, MaXFlow, and SDH, with similar vertical focus on biopharma and materials R&D.
• Schrödinger: Schrödinger is a leading physics-based molecular simulation and AI drug design platform used by biopharma companies. Directly competes with NeoTrident's MaXFlow molecular simulation and AI platform for small molecule and biologics design customers, including in the Chinese market where Schrödinger is expanding.

Broad incumbents

• Certara: Certara provides PK/PD modeling (Phoenix WinNonlin), CDISC compliance (Pinnacle 21), and regulatory drug development software. Overlaps with NeoTrident's PK/PD and CDISC platforms while also being a distribution partner for NeoTrident in China.
• PerkinElmer Signals (Revvity): PerkinElmer Signals (now part of Revvity) provides life sciences informatics and ELN solutions (e.g., Signals Notebook, Tioga). Competes with NeoTrident's iLabPower ELN but as part of a much broader analytical instruments and services portfolio.
• BIOVIA (Dassault Systèmes): BIOVIA provides broad life sciences and materials science R&D software including BIOVIA Discovery Studio (molecular modeling) and ELN solutions. Competes with NeoTrident's MaXFlow and iLabPower but as a portfolio-wide incumbent with deeper global reach and significantly larger R&D budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeoTrident